+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019

  • ID: 4760850
  • Drug Pipelines
  • 777 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Celldex Therapeutics Inc
  • Eureka Therapeutics Inc
  • Kiromic Inc
  • NantKwest Inc
  • MORE
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline landscape.

Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes. Symptoms include painless swelling of the lymph nodes in the neck, armpits, or groin, fever and chills, night sweats, weight loss, loss of appetite and itchy skin. Hodgkin lymphoma is most common among people ages 15 to 35 and 50 to 70. Past infection with the Epstein-Barr virus (EBV) and HIV infection are at increased risk compared to the general population. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

This latest pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Unknown stages are 2, 2, 43, 29, 1, 13 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 6, 3, 2 and 1 molecules, respectively.

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from 's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Celldex Therapeutics Inc
  • Eureka Therapeutics Inc
  • Kiromic Inc
  • NantKwest Inc
  • MORE
Introduction

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Overview

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Therapeutics Development

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Therapeutics Assessment

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Companies Involved in Therapeutics Development

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Drug Profiles

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Dormant Projects

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Discontinued Products

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Products under Development by Companies, H1 2019

Products under Development by Universities/Institutes, H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by AbbVie Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Actinium Pharmaceuticals Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by ADC Therapeutics SA, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Aduro BioTech Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Affimed GmbH, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by AlfaSigma SpA, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Alissa Pharma, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Apollomics Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Astellas Pharma Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by AstraZeneca Plc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Aurigene Discovery Technologies Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by BeiGene Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Bristol-Myers Squibb Co, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Carrick Therapeutics Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Celgene Corp, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Cell Medica Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Celldex Therapeutics Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Cellectar Biosciences Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Cellectis SA, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Celleron Therapeutics Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Cellestia Biotech AG, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Cellular Biomedicine Group Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Celularity Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Checkpoint Therapeutics Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Chipscreen Biosciences Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Constellation Pharmaceuticals Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Curis Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Eureka Therapeutics Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Faron Pharmaceuticals Oy, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by FLX Bio Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Immunomedics Inc, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Incyte Corp, H1 2019

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline by Inhibrx LP, H1 2019

List of Figures

Number of Products under Development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Top 10 Routes of Administration, H1 2019

Number of Products by Stage and Top 10 Routes of Administration, H1 2019

Number of Products by Top 10 Molecule Types, H1 2019

Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AbbVie Inc
  • Actinium Pharmaceuticals Inc
  • ADC Therapeutics SA
  • Aduro BioTech Inc
  • Affimed GmbH
  • AlfaSigma SpA
  • Alissa Pharma
  • Anhui Anke Biotechnology (Group) Co Ltd
  • Apollomics Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Aurigene Discovery Technologies Ltd
  • BeiGene Ltd
  • Biohaven Pharmaceutical Holding Company Ltd
  • Bristol-Myers Squibb Co
  • Carrick Therapeutics Ltd
  • Celgene Corp
  • Cell Medica Ltd
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Cellectis SA
  • Celleron Therapeutics Ltd
  • Cellestia Biotech AG
  • Cellular Biomedicine Group Inc
  • Celularity Inc
  • Checkpoint Therapeutics Inc
  • Chipscreen Biosciences Ltd
  • Constellation Pharmaceuticals Inc
  • Curis Inc
  • Eureka Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • FLX Bio Inc
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Immunomedics Inc
  • Incyte Corp
  • Inhibrx LP
  • Jiangsu Hengrui Medicine Co Ltd
  • Kiromic Inc
  • Kite Pharma Inc
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Molecular Templates Inc
  • NantKwest Inc
  • NBE-Therapeutics AG
  • Recursion Pharmaceuticals Inc
  • Regeneron Pharmaceuticals Inc
  • Rhizen Pharmaceuticals SA
  • Rich Pharmaceuticals Inc
  • Sanofi
  • Seattle Genetics Inc
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
  • Shanghai Junshi Bioscience Co Ltd
  • Shanghai Pharmaceutical Group Co Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Stemline Therapeutics Inc
  • Syndax Pharmaceuticals Inc
  • TaiGen Biotechnology Co Ltd
  • Taiwan Liposome Co Ltd
  • Trillium Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4760850
Adroll
adroll